Latest Conference Articles

Treating atrial fibrillation by ablation is equally effective whether done by freezing or burning small parts of the heart.

In the real world, which patients get P2Y inhibitors? A Mount Sinai team investigated.

A newer version of a valve system used in transcatheter aortic valve replacement has proved superior to surgery in elderly patients. The study was released a day after a report on the older device showed it was as good as surgery.

A large genetic analysis showed that the incidence of a single genetic mutation in familial hypercholesterolemia patients is smaller than thought--but that those who do have the mutation face a far higher risk of heart disease.

Reportingg on a trial known as ACCELERATE, researchers said a powerful CETP inhibitor did not reduce cardiovascular events, despite having “Profound HDL-C raising and LDL-C lowering propertie

There were hundreds of presentations on high-tech innovations and the latest drugs for heart disease. But unless cardiologists find better ways to prevent cardiovascular illness, deaths will keep rising, the ACC's Kim Williams, MD said in his welcome speech.

When patients are statin-intolerant but have high cholesterol, physicians have other options, a Cleveland Clinic study finds.

An Italian team looked at using novel oral anticoagulants (NOAC) as an alternative to warfarin. The NOAC drugs are safer, they reported.

Population health—the quest to improve the physical well-being of people around the world—is increasingly focused on prevention. But giving antihypertensives plus statins to people who do not have high blood pressure has risks.

Trans Aortic Valve Replacement, a less invasive procedure than open heart surgery, offers about the same benefits but slightly different risks, researchers reported today.

Stress directly impacts the arteries. Imaging studies enable physicians to actually see the proof, a Boston, MA team reports.

Despite demographic shifts that are steadily increasing how long people are living,most medical research lumps everyone over 65 (or even over 60) into the same group. That's about to change, say's NYU's John A. Dodson, MD, MPH.

In findings that shocked the Cleveland Clinic researchers who compiled them, heart attack patients are getting younger and have more comorbidities than expected.

Peripartum cardiomyopathy, a dangerous heart condition that can present in the last month of pregnancy, can lead to major cardiac events. Researchers have found a way to evaluate risk using a biomarker, galectin-3.

Conduction abnormalities in patients who undergo transcatheter aortic valve replacement and then need a pacemaker can be worrisome. A Pittsburghm PA team looked at how these patients fared.

In systolic heart failure, a fixed dose combinatin of isosorbide dinitrate and hydralazine is more effective in black patients. Building on that information, researchers in Pittsburgh looked at ways to use a genomic score to predict which patients would benefit most.

Blood lactate levels can predict short-term prognosis in patients who have had primary percutaneous coronary interventions after an acute myocardial infarction

Despite corrective surgery known as the Fontan procedure, children who need that procedure have ongoing deficits.

Swedish researchers have developed a way to predict major bleeding in revascularized patients who have acute coronary syndrome.

In hospitalized patients with left main acute coronary symptom (LM-ACS), electrocardiographic characteristics can predict prognosis.

Microcalcifications that can show up on mammograms can also predict a woman's risk of heart disease. MD Magazine spoke to Khurram Nasir, MD, co-author of an editorial urging physicians and their specialty societies to put this finding into practice.

In a potentially practice-changing finding, New York researchers found mammograms can predict coronary arterial calcifications and heart disease risk.

There are more than a dozen treatment options for patients with relapsing multiple sclerosis and so far none for the progressive form. Why that is and what can be done to change that are two of the biggest challenges in the field today.

Some of the finest minds in the field of multiple sclerosis were in New Orleans for the annual ACTRIMS conference all looking to share their knowledge and learn more before returning home to their patients.

Trips to the emergency department (ED) can range from the most benign to the most serious of reasons.

As researchers focus on finding treatments for progressive multiple sclerosis there are a number of potential angles to study to find the best treatment options possible. One potential area is the role of B cells in the treatment process.

Recently, researchers had discovered that HIV infection might decrease the risk of developing multiple sclerosis (MS).

New research has discovered high doses of biotin vastly improve neurologic function in a small percentage of patients afflicted with progressive MS.

Gut microbiota has been a trending area of study across all medical specialties, and poses a curious question in multiple sclerosis (MS) research.

While newer medications are constantly being developed for multiple sclerosis one of the original options may still be the best for some patients.